Vis enkel innførsel

dc.contributor.authorSteen, Nils Eiel
dc.contributor.authorAas, Monica
dc.contributor.authorSimonsen, Carmen Elisabeth
dc.contributor.authorDieset, Ingrid
dc.contributor.authorTesli, Martin Steen
dc.contributor.authorNerhus, Mari
dc.contributor.authorGardsjord, Erlend Strand
dc.contributor.authorMørch, Ragni Helene
dc.contributor.authorAgartz, Ingrid
dc.contributor.authorMelle, Ingrid
dc.contributor.authorVaskinn, Anja
dc.contributor.authorSpigset, Olav
dc.contributor.authorAndreassen, Ole Andreas
dc.date.accessioned2020-04-20T08:36:16Z
dc.date.available2020-04-20T08:36:16Z
dc.date.created2017-01-09T15:03:40Z
dc.date.issued2016
dc.identifier.citationInternational journal of bipolar disorders. 2016, 4 (24)en_US
dc.identifier.issn2194-7511
dc.identifier.urihttps://hdl.handle.net/11250/2651625
dc.description.abstractBackground Mood stabilizers like lithium and anticonvulsants are used in bipolar and related psychotic disorders. There is a lack of knowledge of the relationship of these medications and cognition in the psychosis spectrum. We studied the association between serum concentration of mood stabilizers and cognitive performance in a well-characterized sample of bipolar and schizophrenia spectrum disorders. Methods Serum concentrations of valproate, lamotrigine, and lithium were analyzed for associations to performance on neuropsychological tests in six cognitive domains in individuals with bipolar disorder (n = 167) and in a combined sample of individuals with bipolar or schizophrenia spectrum disorders (n = 217). Linear regression with adjustments for gender, age, and symptom levels of depression, mania, and psychosis were applied for the association analyses. Results There were negative associations between serum levels of valproate and short term delayed recall (bipolar: p = 0.043; combined: p = 0.044) and working memory (bipolar: p = 0.043). A positive association was suggested between serum level of lithium and working memory (bipolar: p = 0.039). There were no other significant relationships between serum levels of valproate, lamotrigine, or lithium and neuropsychological test performance in neither the bipolar disorder nor the combined group. Conclusions Serum levels of mood stabilizers were unrelated to cognitive performance in most domains, indicating that higher dose does not lead to broader cognitive impairments in bipolar and related psychotic disorder patients. However, worsened memory with increasing levels of valproate suggests cautious dosing of anticonvulsants, while increasing lithium level seems to be associated with improved memory. The findings should be interpreted with caution due to the explorative, naturalistic design.en_US
dc.language.isoengen_US
dc.publisherSpringer Verlagen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleSerum concentrations of mood stabilizers are associated with memory, but not other cognitive domains in psychosis spectrum disorders; explorative analyses in a naturalistic settingen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.volume4en_US
dc.source.journalInternational journal of bipolar disordersen_US
dc.source.issue24en_US
dc.identifier.doi10.1186/s40345-016-0067-z
dc.identifier.cristin1423578
dc.description.localcodeOpen Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal